TrialInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2014

Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer.

Rachel N Grisham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.